Bringing the Oncology Community Together

Avastin¢ç (bevacizumab) Plus IFN in mRCC

Dr Ronald Bukowski, Professor Emeritus at Cleveland Clinic¡¯s Taussig Cancer Institute, and Dr Thomas Hutson, genitourinary medical oncologist at Baylor University Medical Center, present this educational and interactive guide reviewing metastatic renal cell carcinoma (mRCC). This iPub presentation has been designed to address important issues of clinical significance for physicians treating metastatic kidney cancer.

This interactive guide was designed to provide informative and invaluable data that helps physicians provide the most effective evidence-based care possible for their patients. The clinical topics of this interactive publication delve deeper into the use of bevacizumab plus interferon alfa for patients with metastatic renal cell carcinoma.

View more interactive publications
External Resources

American Journal of Managed Care
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
OncLive Resources

OncLive TV
Oncology Nurses
Web Exclusives

About Us
Advisory Board
Contact Us
Forgot Password
Privacy Policy
Terms & Conditions
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright OncLive 2006-2014
Intellisphere, LLC. All Rights Reserved.